Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Health-Care Deals Make Explosive Start to 2014
Motley Fool
Mon, 03/3/14 - 09:13 pm
Actavis
Forest Labs
JNJ
AstraZeneca
Bristol-Myers Squibb
Aptalis
M&A
AbbVie Hepatitis C Combo Cures Almost All in Late Study
Bloomberg
Mon, 03/3/14 - 06:46 pm
AbbVie
hepatitis C
ABT-450
ABT-267
ABT-333
Gilead Sciences
Bristol-Myers Squibb
Durable melanoma remission seen with Bristol immunotherapy drug
Yahoo/Reuters
Mon, 03/3/14 - 06:44 pm
Bristol-Myers Squibb
nivolumab
melanoma
metastatic melanoma
This Week in Biotech: 2 FDA Approvals and 3 Clinically Impressive Studies
Motley Fool
Sun, 03/2/14 - 11:59 am
Myalept
leptin deficiency
lipodystrophy
Astra Zeneca
Bristol-Myers Squibb
Anika
Monovisc
osteoarthritis
osteoarthritis of the knee
[video]Another Day, Another Big Pharma Breakup
Motley Fool
Fri, 02/28/14 - 08:37 am
Merck
consumer health
Bristol-Myers Squibb
Procter & Gamble
Novartis
Eliquis earns best safety score in its class in analysis of FDA adverse event reports
Fierce Pharma
Thu, 02/27/14 - 11:39 am
Eliquis
FDA
Pfizer
Bristol-Myers Squibb
FDA eases worries regarding certain diabetes medications
Yahoo/Fly on the Wall
Thu, 02/27/14 - 08:19 am
FDA
diabetes
Merck
Januvia
Janumet
Novo Nordisk
Victoza
Bristol-Myers Squibb
Byetta
Bydureon
FDA approves Bristol-Myers drug for rare body fat disorder
Yahoo/Reuters
Tue, 02/25/14 - 10:47 am
FDA
Bristol-Myers Squibb
lipodystrophy
Myalept
5 Pharmas Spending the Most to Develop Drugs: Merck, AstraZeneca, Roche, Bristol, and Lilly
Motley Fool
Tue, 02/25/14 - 07:22 am
Merck
AstraZeneca
Roche
Bristol-Myers Squibb
Eli Lilly
R&D
drug development
Bristol-Myers Squibb Receives U.S. FDA Breakthrough Therapy Designation for All-Oral Daclatasvir Dual Investigational Regimen for Chronic Hepatitis C
Yahoo
Mon, 02/24/14 - 09:55 am
daclatasvir
breakthrough therapies
FDA
Bristol-Myers Squibb
hepatitis C
Does Bristol-Myers Squibb Co. Have Any Fuel Left in its Tank?
Motley Fool
Sat, 02/22/14 - 11:23 am
Bristol-Myers Squibb
2 FDA Decisions You Need to Watch Next Week
Motley Fool
Fri, 02/21/14 - 05:12 pm
FDA
metreleptin
Bristol-Myers Squibb
lipodystrophy
AstraZeneca
hypogonadism
Endo Health Solutions
Aveed
Bristol-Myers reports positive results from Phase 3 ARISTOTLE trial
Yahoo/Fly on the Wall
Fri, 02/21/14 - 11:16 am
Bristol-Myers Squibb
Pfizer
Eliquis
bloodthinners
Immune Checkpoint Blocker Race Heats Up
Wall St Cheat Sheet
Tue, 02/18/14 - 10:19 am
immune checkpoint blockers
Yervoy
Bristol-Myers Squibb
MK-3475
Merck
3 Promising Biotechs for 2014: Ariad, Bristol-Myers, Sanomedics
Wall St Cheat Sheet
Fri, 02/14/14 - 10:36 am
Ariad Pharmaceuticals
Bristol-Myers Squibb
Sanomedics
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Seeking Alpha
Wed, 02/12/14 - 09:14 am
cancer immunotherapy
Merck
Bristol-Myers Squibb
Amgen
Incyte
Pfizer
MK-3475
Ablynx
Yervoy
3 Major Health-Care Deals You Need to Know About
Motley Fool
Tue, 02/11/14 - 04:48 pm
Forest Labs
Aptalis
Bristol-Myers Squibb
AstraZeneca
JNJ
Can drug makers find profit in collaboration?
Forbes
Tue, 02/11/14 - 04:45 pm
NIH
Bristol-Myers Squibb
Pfizer
GSK
Eli Lilly
Merck
Amgen
Bristol-Myers Has A Bright Future Outlook
Seeking Alpha
Fri, 02/7/14 - 09:39 am
Bristol-Myers Squibb
earnings
Here's Why Big Pharma is Rooting for Portola
Motley Fool
Wed, 02/5/14 - 10:23 am
Portola Pharmaceuticals
Pfizer
JNJ
Bayer
Bristol-Myers Squibb
Xarelto
Eliquis
Pages
« first
‹ previous
…
49
50
51
52
53
54
55
56
57
…
next ›
last »